e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.95p
   
  • Change Today:
    -0.25p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 1,065,155
  • Market Cap: £58.14m

Latest Deals

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Director Shareholdings

Notifier Holding Value*
Ali Mortazavi 50,941,666 £5,068,696
Trevor Mervyn Jones 1,293,896 £128,743
Michael Anthony Bretherton 500,000 £49,750

Major Shareholders

Notifier** Holding Value*
Richard Griffiths 170,510,905 £16,965,835
M&G Plc 101,875,000 £10,136,562
Robert Quested 52,000,000 £5,174,000
Trillian Ltd 29,769,326 £2,962,048
Henderson Global Investors 26,445,958 £2,631,373
David Richardson 24,779,030 £2,465,514
Lombard Odier Asset Management (Europe) Limited 20,965,820 £2,086,099
Rupert Labrum 17,162,547 £1,707,673
Gartmore Investment Limited 6,541,000 £650,830
Credit Suisse Client Nominees (UK) Limited 4,557,950 £453,516

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.95p
Change Today -0.25p
% Change -2.45 %
52 Week High 23.10
52 Week Low 8.13
Volume 1,065,155
Shares Issued 584.34m
Market Cap £58.14m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Price Trend
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Income Not Available
Growth
15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
15:14 833,500 @ 10.20p
16:28 59 @ 9.55p
15:52 7,752 @ 10.19p
13:15 21,341 @ 9.78p
13:06 14,311 @ 9.78p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page